Navigation Links
Antisense gene specific therapy for Ebola virus

Professor Sina Bavari and team from the U.S. Army Medical Research Institute of Infectious Diseases have found that antisense genetic sequence of the Ebola virus could help protection and treatment of humans // from wild strains of Ebola virus. This therapy is very important and still more has to be done as this Ebola virus offers a great threat of bioterrorism. The results of this research work are published in the Journal Public Library of Science Pathogens.

Ebola virus causes Viral Hemorrhagic Syndrome causing a very high increase of virus in blood leading to an ineffective immunological protection by the host against the virus leading necrosis. Morbidity and mortality is very high and varies according to the strain involved and no effective treatment has been found against the virus and interestingly virus has been isolated from the semen of infected person.

Antisense drugs binds to the replication site of the virus and due to the mismatch pairing it does not lead to replication of virus causing the reduction of the virus. A Combination of three Antisense Phosphorodiamidate Morpholino Oligomers (PMOs) was first tested on laboratory mice followed by experiments on guinea pigs and rhesus monkeys and the researchers found that the Antisense PMOs effectively inhibits the growth of the virus and the researchers are planning to further expand their study on antisense PMOs against Ebola virus.


'"/>




Page: 1

Related medicine news :

1. Gene testing kit specific for Doctors
2. Dental appointment fear: is it gender specific?
3. Child specific HIV drugs and laboratory tests should be developed
4. Acupuncture May Help Chemotherapy Side Effects
5. Antioxidants protect health tissue in people undergoing radiation therapy.
6. Distraction therapy found very effective in postoperative patients
7. Acupuncture superseeds massage therapy for short term relief of pain
8. Ovarian cancer in relationship with Hormone therapy
9. New therapy better at increasing bone density
10. Gene therapy - Aim to improve blood flow
11. Gene therapy restores sight
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: